Literature DB >> 23597962

Behçet's syndrome.

Gulen Hatemi1, Yusuf Yazici, Hasan Yazici.   

Abstract

Behçet's syndrome (BS) shows a peculiar distribution, with a much higher prevalence in countries along the ancient Silk Road compared with rest of the world. BS also seems to follow a more severe course in ethnic groups with higher prevalence. Diagnosis depends on clinical findings. Criteria sets may not help in patients with less frequent types of involvement. Management strategies should be modified according to the age and sex of the patient and the organs involved. Being a serious health problem in endemic areas, BS also attracts global attention as a model to study inflammatory diseases of unknown cause.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23597962     DOI: 10.1016/j.rdc.2013.02.010

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  30 in total

1.  Immunometabolic biomarkers of inflammation in Behçet's disease: relationship with epidemiological profile, disease activity and therapeutic regimens.

Authors:  L Cantarini; V Pucino; A Vitale; R Talarico; O M Lucherini; F Magnotti; V De Rosa; M Galgani; C Alviggi; G Marone; M Galeazzi; G Matarese
Journal:  Clin Exp Immunol       Date:  2016-02-24       Impact factor: 4.330

2.  Do clinical findings of Behçet's disease vary by gender?: A single-center experience from 329 patients.

Authors:  Döndü Üsküdar Cansu; Timuçin Kaşifoğlu; Cengiz Korkmaz
Journal:  Eur J Rheumatol       Date:  2016-12-01

3.  Serum amyloid-A in Behçet's disease.

Authors:  Antonio Vitale; Donato Rigante; Giuseppe Lopalco; Maria Giuseppina Brizi; Francesco Caso; Rossella Franceschini; Rosario Denaro; Mauro Galeazzi; Leonardo Punzi; Florenzo Iannone; Giovanni Lapadula; Antonella Simpatico; Edoardo Marrani; Luisa Costa; Rolando Cimaz; Luca Cantarini
Journal:  Clin Rheumatol       Date:  2014-08       Impact factor: 2.980

4.  Cerebral venous sinus thrombosis in Behçet's disease: a retrospective case-control study.

Authors:  Jing Shi; Xinxiang Huang; Guohua Li; Li Wang; Jinjing Liu; Yan Xu; Xiaofeng Zeng; Wenjie Zheng
Journal:  Clin Rheumatol       Date:  2017-06-14       Impact factor: 2.980

5.  Assessment of genotoxicity associated with Behcet's disease using sister-chromatid exchange assay: vitamin E versus mitomycin C.

Authors:  Omar F Khabour; Khaldon Alawneh; Etizaz Al-Kofahi; Fahmee Mesmar
Journal:  Cytotechnology       Date:  2014-05-23       Impact factor: 2.058

6.  Development of de novo major involvement during follow-up in Behçet's syndrome.

Authors:  Rosaria Talarico; Luca Cantarini; Anna d'Ascanio; Michele Figus; Benedetta Favati; Chiara Baldini; Chiara Tani; R Neri; Stefano Bombardieri; Marta Mosca
Journal:  Clin Rheumatol       Date:  2015-03-08       Impact factor: 2.980

Review 7.  Update on the therapy of Behçet disease.

Authors:  Zeinab Saleh; Thurayya Arayssi
Journal:  Ther Adv Chronic Dis       Date:  2014-05       Impact factor: 5.091

8.  HLA-B*51 the primary risk in Behçet disease.

Authors:  Graham R Wallace
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-29       Impact factor: 11.205

Review 9.  Role of genetics in pediatric rheumatology.

Authors:  Eda Tahir Turanlı; Elif Everest; Ayşe Balamir; Aslı Kireçtepe Aydın; Özgür Kasapçopur
Journal:  Turk Pediatri Ars       Date:  2017-09-01

Review 10.  Headache in Behçet's syndrome: review of literature and NYU Behçet's syndrome center experience.

Authors:  Vijay Vishwanath; Ericka Wong; Sara C Crystal; Matthew S Robbins; Maria Filopoulos; Richard B Lipton; Yusuf Yazici; Ilya Kister
Journal:  Curr Pain Headache Rep       Date:  2014-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.